These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 29667881)
1. The ability of ADC measurements in the assessment of patients with stage I endometrial carcinoma based on three risk categories. Liu J; Yuan F; Wang S; Chen X; Ma F; Zhang G; Tian X Acta Radiol; 2019 Jan; 60(1):120-128. PubMed ID: 29667881 [TBL] [Abstract][Full Text] [Related]
2. Utility of the relative apparent diffusion coefficient for preoperative assessment of low risk endometrial carcinoma. Shen Y; Lv F; Xiao Z; Bi Q Clin Imaging; 2019; 56():28-32. PubMed ID: 30851496 [TBL] [Abstract][Full Text] [Related]
3. Can the apparent diffusion coefficient differentiate the grade of endometrioid adenocarcinoma and the histological subtype of endometrial cancer? Yan B; Zhao T; Liang X; Niu C; Ding C Acta Radiol; 2018 Mar; 59(3):363-370. PubMed ID: 28696169 [TBL] [Abstract][Full Text] [Related]
4. Pathological characteristics and risk stratification in patients with stage I endometrial cancer: utility of apparent diffusion coefficient histogram analysis. An T; Kim CK Br J Radiol; 2021 Oct; 94(1126):20210151. PubMed ID: 34233478 [TBL] [Abstract][Full Text] [Related]
5. The value of the apparent diffusion coefficient in differentiating type II from type I endometrial carcinoma. Chen J; Fan W; Gu H; Wang Y; Liu Y; Chen X; Ren S; Wang Z Acta Radiol; 2021 Jul; 62(7):959-965. PubMed ID: 32727213 [TBL] [Abstract][Full Text] [Related]
6. The prominent value of apparent diffusion coefficient in assessing high-risk factors and prognosis for patients with endometrial carcinoma before treatment. Quan Q; Lu Y; Xuan B; Wu J; Yin W; Hua Y; Chen R; Ren S; Zhou S; Zhang F; Meng Y; Rao K; Mu X Acta Radiol; 2021 Jun; 62(6):830-838. PubMed ID: 32702999 [TBL] [Abstract][Full Text] [Related]
7. Evaluation and validation of the diagnostic value of the apparent diffusion coefficient for differentiating early-stage endometrial carcinomas from benign mimickers at 3T MRI. Wang X; Zhao Y; Hu Y; Zhou Y; Ye X; Liu K; Bai G; Guo A; Du M; Jiang L; Wang J; Yan Z Oncotarget; 2017 Jul; 8(28):46390-46397. PubMed ID: 28634318 [TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of diffusion-kurtosis imaging for grading endometrial carcinoma: a comparative study with diffusion-weighted imaging. Chen T; Li Y; Lu SS; Zhang YD; Wang XN; Luo CY; Shi HB Clin Radiol; 2017 Nov; 72(11):995.e11-995.e20. PubMed ID: 28774471 [TBL] [Abstract][Full Text] [Related]
9. Multi-b-value diffusion weighted imaging for preoperative evaluation of risk stratification in early-stage endometrial cancer. Zhang Q; Yu X; Lin M; Xie L; Zhang M; Ouyang H; Zhao X Eur J Radiol; 2019 Oct; 119():108637. PubMed ID: 31446209 [TBL] [Abstract][Full Text] [Related]
10. Is the standard deviation of the apparent diffusion coefficient a potential tool for the preoperative prediction of tumor grade in endometrial cancer? Yan B; Liang X; Zhao T; Ding C; Zhang M Acta Radiol; 2020 Dec; 61(12):1724-1732. PubMed ID: 32366108 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the value of diffusion kurtosis imaging and diffusion-weighted imaging in evaluating the histological features of endometrial cancer. Yue W; Meng N; Wang J; Liu W; Wang X; Yan M; Han D; Cheng J Cancer Imaging; 2019 Feb; 19(1):9. PubMed ID: 30764876 [TBL] [Abstract][Full Text] [Related]
12. Utility of histogram analysis of apparent diffusion coefficient maps obtained using 3.0T MRI for distinguishing uterine carcinosarcoma from endometrial carcinoma. Takahashi M; Kozawa E; Tanisaka M; Hasegawa K; Yasuda M; Sakai F J Magn Reson Imaging; 2016 Jun; 43(6):1301-7. PubMed ID: 26605502 [TBL] [Abstract][Full Text] [Related]
14. Whole-lesion apparent diffusion coefficient (ADC) histogram as a quantitative biomarker to preoperatively differentiate stage IA endometrial carcinoma from benign endometrial lesions. Zhang J; Yu X; Zhang X; Chen S; Song Y; Xie L; Chen Y; Ouyang H BMC Med Imaging; 2022 Aug; 22(1):139. PubMed ID: 35941559 [TBL] [Abstract][Full Text] [Related]
15. Utility of diffusion-weighted imaging in association with pathologic upgrading in biopsy-proven grade I endometrial cancer. Park JJ; Kim CK; Cho SW; Kim JH J Magn Reson Imaging; 2020 Jan; 51(1):117-123. PubMed ID: 31206949 [TBL] [Abstract][Full Text] [Related]
16. The volumetric ADC histogram analysis in differentiating stage IA endometrial carcinoma from endometrial polyp. Zhao Y; You C; Zhou X; Li X; Zhang C; Wu Y; Shen W Br J Radiol; 2024 May; 97(1158):1139-1145. PubMed ID: 38662891 [TBL] [Abstract][Full Text] [Related]
17. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones. Kilickesmez O; Bayramoglu S; Inci E; Cimilli T; Kayhan A Acta Radiol; 2009 Apr; 50(3):340-7. PubMed ID: 19235579 [TBL] [Abstract][Full Text] [Related]
18. Role of magnetic resonance imaging and apparent diffusion coefficient at 3T in distinguishing between adenocarcinoma of the uterine cervix and endometrium. Lin YC; Lin G; Chen YR; Yen TC; Wang CC; Ng KK Chang Gung Med J; 2011; 34(1):93-100. PubMed ID: 21392479 [TBL] [Abstract][Full Text] [Related]
19. [The value of T2 mapping for evaluating the pathological type, grade and depth of myometrial invasion in endometrial carcinoma]. Li SJ; Zhang ZX; Liu J; Wang WJ; Wang J; Zhang Y; Cheng JL Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):673-680. PubMed ID: 37580272 [No Abstract] [Full Text] [Related]
20. Diffusion-weighted MRI in the differential diagnosis of uterine endometrial cavity tumors. Karakas O; Karakas E; Dogan F; Kilicaslan N; Camuzcuoglu A; Incebiyik A; Camuzcuoglu H Wien Klin Wochenschr; 2015 Apr; 127(7-8):266-73. PubMed ID: 25708066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]